Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
The Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) research funding from the National Institutes of Health (NIH) supports mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites, and contexts in which expectancy effects can be leveraged to improve cancer outcomes. Expectancies are defined in this context as beliefs about future outcomes, including one’s response to cancer or cancer treatment. Expectancies can be evoked by social, psychological, environmental, and systemic factors. Program is particularly interested in applications that enroll individuals and groups from populations historically underrepresented or excluded from biomedical and behavioral research. Applications are open to researchers at research institutions in the USA and worldwide, including small businesses and other for-profit organizations. The grant provides funding for up to 5 years. The proposed budget should reflect the actual costs of the study.
Funding opportunity number: PAR-23-273
Applications are due on February 5, 2024.